BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17355265)

  • 1. ADAMs in cancer cell proliferation and progression.
    Mochizuki S; Okada Y
    Cancer Sci; 2007 May; 98(5):621-8. PubMed ID: 17355265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
    Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
    Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
    Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
    Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
    Okada Y
    Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of ADAM (a disintegrin and metalloproteinase) genes between human first trimester villous and extravillous trophoblast cells.
    Takahashi H; Yuge K; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Suzuki M; Takizawa T
    J Nippon Med Sch; 2014; 81(3):122-9. PubMed ID: 24998958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Disintegrin and Metalloproteinase (ADAM) Family: Their Significance in Malignant Tumors of the Central Nervous System (CNS).
    Łukaszewicz-Zając M; Dulewicz M; Mroczko B
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system.
    Hsia HE; Tüshaus J; Brummer T; Zheng Y; Scilabra SD; Lichtenthaler SF
    Cell Mol Life Sci; 2019 Aug; 76(16):3055-3081. PubMed ID: 31236626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview.
    Takeda S
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27196928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ADAMs family of proteases as targets for the treatment of cancer.
    Mullooly M; McGowan PM; Crown J; Duffy MJ
    Cancer Biol Ther; 2016 Aug; 17(8):870-80. PubMed ID: 27115328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ADAMs in cancer formation and progression.
    Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
    Clin Cancer Res; 2009 Feb; 15(4):1140-4. PubMed ID: 19228719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
    Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
    Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.
    Yang CY; Chanalaris A; Troeberg L
    Osteoarthritis Cartilage; 2017 Jul; 25(7):1000-1009. PubMed ID: 28216310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of integrin-mediated cell migration by distinct ADAM family members.
    Huang J; Bridges LC; White JM
    Mol Biol Cell; 2005 Oct; 16(10):4982-91. PubMed ID: 16079176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
    Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
    Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ADAMs: signalling scissors in the tumour microenvironment.
    Murphy G
    Nat Rev Cancer; 2008 Dec; 8(12):929-41. PubMed ID: 19005493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ADAM metalloproteinases.
    Edwards DR; Handsley MM; Pennington CJ
    Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
    Yang H; Khalil RA
    Adv Pharmacol; 2022; 94():255-363. PubMed ID: 35659374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.